Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines
Diabetes, Obesity and Metabolism · 2026-10 · 28 (10) · 8847-8860
DOI: 10.1111/dom.71066 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 08.07.2026. Verfasst von Michelle Damgaard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Autonomic Nervous System Diseases, Cardiovascular Diseases, Cytokines, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Aims
Cardiovascular autonomic neuropathy (CAN) is a severe form of diabetic neuropathy affecting approximately one in five people with diabetes and is a major predictor of cardiovascular mortality. Low‐grade inflammation may contribute to CAN development, but the exact inflammatory factors associated with CAN remain unclear. Here, we examined the circulating levels of cytokines across different stages of CAN severity in individuals with type 2 diabetes (T2D). Materials and Methods From an initial T2D cohort with 899 participants undergoing cardiovascular autonomic reflex tests (CARTs) and measures of heart rate variability (HRV) indices, a final sub‐cohort of 249 participants was selected and classified as: no CAN ( n = 83), early CAN ( n = 69) or manifest CAN ( n = 97), according to CARTs. One abnormal test constituted early CAN; two or three abnormal CARTs constituted manifest CAN. Ten cytokines were measured in serum samples using Meso Scale Discovery multiplex technology.
Results
Individuals with manifest CAN exhibited subtle but significantly higher circulating levels of the proinflammatory cytokines interleukin (IL)‐6, tumour necrosis factor (TNF)‐α and interferon (IFN)‐γ compared to the no CAN group. Furthermore, TNF‐α levels tended to be upregulated already in early CAN compared to no CAN. Higher levels of IL‐6, IL‐8, IL‐10, IFN‐γ and TNF‐α were associated with worse autonomic function outcomes, including HRV indices and CARTs.
Conclusion
CAN severity is associated with increased circulating levels of IL‐6, IFN‐γ and TNF‐α in T2D. These cytokines may therefore hold promise as clinically useful biomarkers and/or therapeutic targets to mitigate CAN burden and possibly cardiovascular risk. Trial Registration: Number: NCT05043636; Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2–1.3–1.4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Michelle Damgaard, Tik Muk, Christian Stevns Hansen
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Damgaard, M., Kokla, M., Gerwig, R. H., Mizrak, H. I., Hecquet, S. K., Muk, T., Kaur, G., Brock, B., Hansen, C. S., & Størling, J. (2026). Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines. Diabetes, Obesity and Metabolism, 28(10), 8847-8860. https://doi.org/10.1111/dom.71066
Vancouver
Damgaard M, Kokla M, Gerwig RH, Mizrak HI, Hecquet SK, Muk T, et al. Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines. Diabetes, Obesity and Metabolism. 2026;28(10):8847-8860. doi:10.1111/dom.71066
BibTeX
@article{Damgaard2026,
author = {Damgaard, Michelle and Kokla, Marietta and Gerwig, Rebekka H and Mizrak, Hatice Isik and Hecquet, Sofie Korsgaard and Muk, Tik and Kaur, Gurjeet and Brock, Birgitte and Hansen, Christian Stevns and Størling, Joachim},
title = {Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {10},
pages = {8847--8860},
doi = {10.1111/dom.71066}
}
EUVIMED